Literature DB >> 22722994

CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis.

Young Ho Lee1, Gwan Gyu Song.   

Abstract

The aim of this study was to explore whether cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphisms confer susceptibility to Behcet's disease (BD). A meta-analysis was conducted on the associations between the CTLA-4 +49 A/G, -318 C/T, CT60 A/G polymorphisms and BD using; (1) allele contrast, (2) the recessive model, (3) the dominant model, and (4) the additive model. A total of 8 separate comparison studies on BD were considered in the meta-analysis. Meta-analysis of the CTLA-4 +49 A/G polymorphisms showed no association between BD and the CTLA-4 +49 G allele in all study subjects (odds ratio [OR] = 0.780, 95 % confidence interval [CI] = 0.491-1.240, p = 0.294). Moreover, stratification by ethnicity indicated no association between the CTLA-4 +49 G allele and BD in Turkish population. No association was found between BD and the CTLA-4 +49 A/G polymorphisms using recessive or dominant models or contrast of homozygotes. No association was found between BD and the CTLA-4 -318 C/T or CT60 A/G polymorphisms. This meta-analysis showed that no association was found between CTLA-4 +49 A/G, -318 C/T or CT60 A/G polymorphisms and BD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722994     DOI: 10.1007/s11033-012-1775-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  16 in total

1.  CTLA-4 regulates cell cycle progression during a primary immune response.

Authors:  Rebecca J Greenwald; Mariette A Oosterwegel; Diane van der Woude; Anup Kubal; Didier A Mandelbrot; Vassiliki A Boussiotis; Arlene H Sharpe
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.

Authors:  N Sallakci; A Bacanli; M Coskun; U Yavuzer; E Alpsoy; O Yegin
Journal:  Clin Exp Dermatol       Date:  2005-09       Impact factor: 3.470

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis.

Authors:  Shizhong Han; Yao Li; Yumin Mao; Yi Xie
Journal:  Hum Genet       Date:  2005-08-17       Impact factor: 4.132

7.  CTLA4 mediates antigen-specific apoptosis of human T cells.

Authors:  J G Gribben; G J Freeman; V A Boussiotis; P Rennert; C L Jellis; E Greenfield; M Barber; V A Restivo; X Ke; G S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

8.  CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.

Authors:  Young Ho Lee; John B Harley; Swapan K Nath
Journal:  Hum Genet       Date:  2005-02-02       Impact factor: 4.132

Review 9.  The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.

Authors:  Y H Lee; Y H Rho; S J Choi; J D Ji; G G Song; S K Nath; J B Harley
Journal:  Rheumatology (Oxford)       Date:  2006-06-07       Impact factor: 7.580

10.  CTLA-4 polymorphisms are not associated with ocular inflammatory disease.

Authors:  L Bye; N Modi; M R Stanford; E Kondeatis; R Vaughan; F Fortune; C Kanawati; E Ben-Chetrit; M Ghabra; P I Murray; G R Wallace
Journal:  Tissue Antigens       Date:  2008-05-20
View more
  2 in total

1.  The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease.

Authors:  Sahar M Abdel Galil; Hoda A Hagrass
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

Review 2.  Global Meta-Analysis on the Association between Behcet Syndrome and Polymorphisms from the HLA Class I (A, B, and C) and Class II (DRB1, DQB1, and DPB1) Genes.

Authors:  Cristina Capittini; Chiara Rebuffi; Marco Vincenzo Lenti; Antonio Di Sabatino; Carmine Tinelli; Miryam Martinetti; Annalisa De Silvestri
Journal:  Dis Markers       Date:  2021-12-13       Impact factor: 3.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.